2022
DOI: 10.21203/rs.3.rs-1946623/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The Development of Social Capital in a Peer-Led HIV Adherence Intervention

Abstract: Background: Behavioral health interventions conducted by peers – individuals who share common characteristics, circumstances, or experiences with research participants – have shown promising results. The Adherence Connection for Counseling, Education, and Support (ACCESS) I proof-of-concept study is a peer-led intervention to improve HIV medication adherence in youth living with HIV who are in treatment but have detectable viral loads. Participants received five online sessions with peer health coaches who fol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…27,32 Some expressed concerns about reduced vigilance or oversight of patients (Goldsamt, 2021), 33 or feared scrutiny of practices and outcomes by federal and state agencies . 31 Many expressed concerns about how take-home dosing would reduce revenue , Goldsamt, 2021, Hunter, 2021). 22,31,33,34 Some noted concerns around legal liability for potential overdose or diversion of methadone, which made them apprehensive about take-home dosing long-term , Hunter, 2021, Madden, 2021).…”
Section: B Findings and Implications For Federal Regulatorsmentioning
confidence: 99%
See 2 more Smart Citations
“…27,32 Some expressed concerns about reduced vigilance or oversight of patients (Goldsamt, 2021), 33 or feared scrutiny of practices and outcomes by federal and state agencies . 31 Many expressed concerns about how take-home dosing would reduce revenue , Goldsamt, 2021, Hunter, 2021). 22,31,33,34 Some noted concerns around legal liability for potential overdose or diversion of methadone, which made them apprehensive about take-home dosing long-term , Hunter, 2021, Madden, 2021).…”
Section: B Findings and Implications For Federal Regulatorsmentioning
confidence: 99%
“…Only patients in treatment fewer than 90 days -which did not receive increases in take-homes -were more likely to discontinue treatment in the COVID period (13% pre-COVID vs. 26% post) (Hoffman, 2022). 39 Beyond patient benefits, many providers expressed appreciation for the new flexibility to make better and more equitable decisions to support needs of their patients (Suen, 2022;Hunter, 2021;Goldsamt, 2021;Treitler, 2022). [32][33][34]36 Some providers also noted that the increased takehome doses during the pandemic permitted greater adherence to treatment and improved autonomy and motivations to change (Treitler, 2022).…”
Section: Potential Benefits Of the Proposed Rulementioning
confidence: 99%
See 1 more Smart Citation